Market Research Logo

Italy Insurance Report Q2 2016

Italy Insurance Report Q2 2016

BMI View: Drugmaker revenue streams will continue to be constrained in Italy as companies will be forcedto refund a significant portion of the regional public pharmaceutical overspend for 2015 and beyond.

Italian regions will continue to struggle to maintain pharmaceutical expenditure below the 3.5% ceiling ofthe national healthcare budget. Although the government may implement measures to contain futurepharmaceutical expenditure, it will be impossible to reverse the trend by the end of 2016.

Headline Expenditure Projections

Pharmaceuticals: EUR21.74bn (USD23.92bn) in 2015 to EUR21.50bn (USD23.01bn) in 2016; -1.1% inlocal currency terms and -3.8% in US dollar terms.

Healthcare: EUR141.14bn (USD155.26bn) in 2015 to EUR141.50bn (USD151.40bn) in 2016; +0.3% inlocal currency terms and -2.5% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Italy 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Italy 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Italy 2012-2020)
Prescription Drugs Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Italy 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Italy 2012-2020)
Generic Drugs Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Italy 2012-2020)
OTC Drug Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Italy 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Italy 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Italy 2014-2020)
Industry Risk Reward Index
Western Europe Risk/Reward Index
Italy Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Italy 2010-2015)
Table: Healthcare Personnel (Italy 2010-2015)
Table: Healthcare Activity (Italy 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
GlaxoSmithKline
Menarini
Novartis
Pfizer
Recordati
Demographic Forecast
Table: Population Headline Indicators (Italy 1990-2025)
Table: Key Population Ratios (Italy 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Italy 1990-2025)
Table: Population By Age Group (Italy 1990-2025)
Table: Population By Age Group % (Italy 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report